Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Basel Medical Group Ltd’s current trading price is -63.54% away from its 52-week high, while its distance from the 52-week low is 44.51%. The stock’s price range during this period has varied between $1.64 and $6.50. The company, active in the Healthcare sector, saw a trading volume of around 10.51 million for the day, considerably higher average daily volume of 0.65 million observed over the last three months.
The Role of Moving Averages and Trading Volume in Technical Analysis
How BMGL’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for BMGL stands at 0.57. Similarly, the long-term debt-to-equity ratio is also 0.21.
BMGL Stock Stochastic Average
As of today, the raw stochastic average of Basel Medical Group Ltd over the last 50 days is at 15.02%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 15.02%. Further, the company’s Stochastic %K and %D values for the last 20 days were 13.58% and 30.63%, respectively.
BMGL Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The metric has seen a significant loss of -46.62% since the start of this calendar year. Over the past 30 days, the price of BMGL has leaped by -46.26%. And in the last five days, it has fallen by -50.42%.
